Source: Eur Respir J, 57 (2) 2003778; 10.1183/13993003.03778-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Martin Kolditz, Tobias Welte. Preventing cardiovascular events after pneumonia with aspirin: one step forward, but still many to go. Eur Respir J, 57 (2) 2003778; 10.1183/13993003.03778-2020

Member's Comments

No comment yet.

Related content which might interest you: Community acquired pneumonia: an increased risk for subsequent cardiovascular events? Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 Aspirin reduces cardiovascular events in patients with pneumonia: a prior event rate ratio analysis in a large primary care database Source: Eur Respir J, 57 (2) 2002795; 10.1183/13993003.02795-2020 Year: 2021 QVA149 does not increase the risk of cardio- and cerebro-vascular events, pneumonia and exacerbation events compared with placebo: A network meta-analysis across multiple safety databases Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Platelet count as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Novel drug-induced respiratory emergencies Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Acute Pneumonia and PSI: is it posible to prevent a cardiovascular event? Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 Comunity acquired legionella pneumonia: cardiovascular events and survival Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 COPD and respiratory viral infections as risk factors for the development of cardiovascular events Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Management of acute pulmonary thrombo-embolic disease (PTE) linking mortality risk to treatment strategies Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Long term course of (chronic) thromboembolic pulmonary hypertension, preceded by silent or unrecognized thromboembolic events Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 Frequency of cardiovascular events in hospitalised patients with community acquired pneumonia Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Macrolide therapy for pneumonia: balancing benefits with cardiovascular risks Source: International Congress 2014 – ERS/JAMA lunchtime session: 2014 highlights Year: 2014 Influence of chronic cardiovascular diseases (CVD) on course and outcome of community-acquired pneumonia (CAP) Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017 Is community-acquired pneumonia an independent risk factor for cardiovascular disease? Source: Eur Respir J 2012; 39: 187-196 Year: 2012 Is community-acquired pneumonia an independent risk factor for cardiovascular disease? Source: Eur Respir J 2011; 39: 187-196 Year: 2012 Interleukin-6 levels as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19 Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021